US Patent 10940156 Neuroactive steroids, compositions, and uses thereof
Patent 10940156 was granted and assigned to SAGE Therapeutics on March, 2021 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10940156 Neuroactive steroids, compositions, and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
